Community-acquired pyelonephritis in pregnancy caused by KPC-producing Klebsiella pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 8, 2015, Pages 4375-4378

  Khatri, Asma ^a,d   Murphy, Nina Naeger ^a   Wiest, Peter ^a,b   Osborn, Melissa ^a,b   Garber, Kathleen ^a   Hecker, Michelle ^a,b   Hurless, Kelly ^e   Rudin, Susan D ^b,e   Jacobs, Michael R ^b,d   Kalayjian, Robert C ^a,b   Salata, Robert A ^b,d   Van Duin, David ^c   Perez, Federico ^b,e   Bonomob, Robert A ^b,e   Paterson, David L ^f   Harris, Patrick N A ^f  

^a METROHEALTH MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^e LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^f UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME; CEFTRIAXONE; FOSFOMYCIN; MEROPENEM; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; CARBAPENEM DERIVATIVE;

ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL STRAIN; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CASE REPORT; CESAREAN SECTION; COMMUNITY ACQUIRED PYELONEPHRITIS; CONTINUOUS INFUSION; DYSURIA; FEMALE; FEVER; FLANK PAIN; FOLLOW UP; GESTATIONAL AGE; HUMAN; KLEBSIELLA PNEUMONIAE; MATERNAL WELFARE; MUCOSAL DRYNESS; NAUSEA; OBSTETRIC PATIENT; PHYSICAL EXAMINATION; PREGNANCY; PREGNANT WOMAN; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; PYELONEPHRITIS; PYURIA; RIGOR; TREATMENT DURATION; TREATMENT OUTCOME; URINALYSIS; URINARY TRACT INFECTION; URINE CULTURE; VOMITING; COMMUNITY-ACQUIRED INFECTIONS; DRUG EFFECTS; INFANT; KLEBSIELLA INFECTIONS; METABOLISM; MICROBIOLOGY; PATHOGENICITY;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CARBAPENEMS; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; INFANT; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; PREGNANCY; PYELONEPHRITIS;

EID: 84940187837     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00553-15     Document Type: Article

References (17)

1. Dotters-Katz SK, Heine RP, Grotegut CA. 2013. Medical and infectious complications associated with pyelonephritis among pregnant women at delivery. Infect Dis Obstet Gynecol 2013:124102. http://dx.doi.org/10.1155/2013/124102.
2. van Duin D, Perez F, Rudin SD, Cober E, Hanrahan J, Ziegler J, Webber R, Fox J, Mason P, Richter SS, Cline M, Hall GS, Kaye KS, Jacobs MR, Kalayjian RC, Salata RA, Segre JA, Conlan S, Evans S, Fowler VG, Jr, Bonomo RA. 2014. Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional network. Antimicrob Agents Chemother 58:4035-4041. http://dx.doi.org/10.1128/AAC.02636-14.
3. Diancourt L, Passet V, Verhoef J, Grimont PA, Brisse S. 2005. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol 43:4178-4182. http://dx.doi.org/10.1128/JCM.43.8.4178-4182.2005.
4. Brisse S, Passet V, Haugaard AB, Babosan A, Kassis-Chikhani N, Struve C, Decre D. 2013. wzi gene sequencing, a rapid method for determination of capsular type for Klebsiella strains. J Clin Microbiol 51:4073-4078. http: //dx.doi.org/10.1128/JCM.01924-13.
5. Nordmann P, Couard JP, Sansot D, Poirel L. 2012. Emergence of an autochthonous and community-acquired NDM-1-producing Klebsiella pneumoniae in Europe. Clin Infect Dis 54:150-151. http://dx.doi.org/10.1093/cid/cir720.
6. Endimiani A, Patel G, Hujer KM, Swaminathan M, Perez F, Rice LB, Jacobs MR, Bonomo RA. 2010. In vitro activity of fosfomycin against blaKPC -containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin. Antimicrob Agents Chemother 54: 526-529. http://dx.doi.org/10.1128/AAC.01235-09.
7. Keating GM. 2013. Fosfomycin trometamol: a review of its use as a single-dose oral treatment for patients with acute lower urinary tract infections and pregnant women with asymptomatic bacteriuria. Drugs 73:1951-1966. http://dx.doi.org/10.1007/s40265-013-0143-y.
8. Kastoris AC, Rafailidis PI, Vouloumanou EK, Gkegkes ID, Falagas ME. 2010. Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria. Eur J Clin Pharmacol 66:359-368. http://dx.doi.org/10.1007/s00228-010-0794-5.
9. Lamoureaux TL, Frase H, Antunes NT, Vakulenko SB. 2012. Antibiotic resistance and substrate profiles of the class A carbapenemase KPC-6. Antimicrob Agents Chemother 56:6006-6008. http://dx.doi.org/10.1128/AAC.01338-12.
10. Ho VP, Jenkins SG, Afaneh CI, Turbendian HK, Nicolau DP, Barie PS. 2011. Use of meropenem by continuous infusion to treat a patient with a bla(kpc-2)-positive Klebsiella pneumoniae blood stream infection. Surg Infect (Larchmt) 12:325-327. http://dx.doi.org/10.1089/sur.2010.072.
11. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. 2012. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18: 268-281. http://dx.doi.org/10.1111/j.1469-0691.2011.03570.x.
12. Doi Y, Paterson DL. 2015. Carbapenemase-producing Enterobacteriaceae. Semin Respir Crit Care Med 36:74-84. http://dx.doi.org/10.1055/s-0035-1544208.
13. MacVane SH, Kuti JL, Nicolau DP. 2014. Prolonging beta-lactam infusion: a review of the rationale and evidence, and guidance for implementation. Int J Antimicrob Agents 43:105-113. http://dx.doi.org/10.1016/j.ijantimicag.2013.10.021.
14. Roberts JA, Paul SK, Akova M, Bassetti M, De Waele JJ, Dimopoulos G, Kaukonen KM, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J, DALI Study. 2014. DALI: defining antibiotic levels in intensive care unit patients: are current beta-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis 58:1072-1083. http://dx.doi.org/10.1093/cid/ciu027.
15. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ, Soper DE. 2011. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52:e103-e120. http://dx.doi.org/10.1093/cid/ciq257.
16. Ode B, Haidl S, Hoffstedt B, Walder M, Ursing J. 1988. Fosfomycin versus ampicillin in the treatment of acute pyelonephritis. Chemioterapia 7:96-100.
17. Meeraus WH, Petersen I, Gilbert R. 2015. Association between antibiotic prescribing in pregnancy and cerebral palsy or epilepsy in children born at term: a cohort study using the Health Improvement Network. PLoS One 10:e0122034. http://dx.doi.org/10.1371/journal.pone.0122034.